Waldman WJ - Search Results

1

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.

Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, Taege AJ, Mossad SB, Kohn D, Long JR, Curtis J, Kalaycio M, Pohlman B, Williams JW. Avery RK, et al. Among authors: waldman wj. Bone Marrow Transplant. 2004 Dec;34(12):1071-5. doi: 10.1038/sj.bmt.1704694. Bone Marrow Transplant. 2004. PMID: 15489872

2

Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.

Avery RK, Mossad SB, Poggio E, Lard M, Budev M, Bolwell B, Waldman WJ, Braun W, Mawhorter SD, Fatica R, Krishnamurthi V, Young JB, Shrestha R, Stephany B, Lurain N, Yen-Lieberman B. Avery RK, et al. Among authors: waldman wj. Transplantation. 2010 Aug 27;90(4):419-26. doi: 10.1097/TP.0b013e3181e94106. Transplantation. 2010. PMID: 20683281

3

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Waldman WJ, et al. Transplantation. 1999 Sep 27;68(6):814-25. doi: 10.1097/00007890-199909270-00014. Transplantation. 1999. PMID: 10515382

4

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Waldman WJ, et al. Intervirology. 1999;42(5-6):412-8. doi: 10.1159/000053979. Intervirology. 1999. PMID: 10702725

5

Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide.

Knight DA, Hejmanowski AQ, Dierksheide JE, Williams JW, Chong AS, Waldman WJ. Knight DA, et al. Among authors: waldman wj. Transplantation. 2001 Jan 15;71(1):170-4. doi: 10.1097/00007890-200101150-00031. Transplantation. 2001. PMID: 11211189

6

Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats.

Zeng H, Waldman WJ, Yin DP, Knight DA, Shen J, Ma L, Meister GT, Chong AS, Williams JW. Zeng H, et al. Among authors: waldman wj. Transplantation. 2005 Jan 15;79(1):17-22. doi: 10.1097/01.tp.0000137334.46155.94. Transplantation. 2005. PMID: 15714164

7

Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.

Chong AS, Zeng H, Knight DA, Shen J, Meister GT, Williams JW, Waldman WJ. Chong AS, et al. Among authors: waldman wj. Am J Transplant. 2006 Jan;6(1):69-75. doi: 10.1111/j.1600-6143.2005.01152.x. Am J Transplant. 2006. PMID: 16433758 Free article.

8

T-cell activation response to allogeneic CMV-infected endothelial cells is not prevented by ganciclovir or foscarnet: implications for transplant vascular sclerosis.

Waldman WJ, LeClaire JD, Knight DA. Waldman WJ, et al. Transplantation. 2002 Jan 27;73(2):314-8. doi: 10.1097/00007890-200201270-00032. Transplantation. 2002. PMID: 11821754

9

Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Bickerstaff A, Gordillo G, Orosz K, Knight DA, Orosz CG. Waldman WJ, et al. Transplantation. 2001 Nov 15;72(9):1578-82. doi: 10.1097/00007890-200111150-00018. Transplantation. 2001. PMID: 11707749

10

Cytolytic activity against allogeneic human endothelia: resistance of cytomegalovirus-infected cells and virally activated lysis of uninfected cells.

Waldman WJ, Knight DA, Adams PW. Waldman WJ, et al. Transplantation. 1998 Jul 15;66(1):67-77. doi: 10.1097/00007890-199807150-00011. Transplantation. 1998. PMID: 9679824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters